Pfizer Inc. (PFE) reported a profit for the first-quarter that increased 45 percent from last year. It raised 2021 guidance driven by the updated expectations for contributions to 2021 performance from COVID-19 vaccine, as well as the strong performance of the business, partially offset by anticipated additional R&D investments into vaccines to protect against COVID-19.
Quarterly revenues rose 45 percent from the prior year. The company reported $3.5 billion in first-quarter sales of its COVID-19 vaccine.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com